Details for New Drug Application (NDA): 010585
✉ Email this page to a colleague
The generic ingredient in LERITINE is anileridine hydrochloride. Additional details are available on the anileridine hydrochloride profile page.
Summary for 010585
Tradename: | LERITINE |
Applicant: | Merck |
Ingredient: | anileridine hydrochloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 25MG BASE | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Complete Access Available with Subscription